Curcumin Blocks Fn-Driven Esophageal Cancer (2026)

Cancer research · Esophageal cancer

Curcumin blocks Fusobacterium nucleatum-driven esophageal squamous cell carcinoma by inhibiting the TLR4/MYD88/TRIF/STAT3 signaling axis, restoring chemotherapy sensitivity in preclinical models.

Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.

Original source

Related signals

• Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
• Clinical Trials Update in Resectable Esophageal Cancer
• Advances in targeted therapy for esophageal cancer
• A review of esophageal cancer research: emerging trends, progress and perspectives
• An esophageal cancer clinical trial - ES3